# Lapatinib for Treatment of Ductal Carcinoma In Situ (DCIS) of the Breast

> **NCT00857714** · NA · TERMINATED · sponsor: **Indiana University** · enrollment: 1 (actual)

## Conditions studied

- Ductal Carcinoma in Situ

## Interventions

- **DRUG:** lapatinib

## Key facts

- **NCT ID:** NCT00857714
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-04
- **Primary completion:** 2010-08
- **Final completion:** 2010-08
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Terminated due to low accrual
- **Last updated:** 2015-07-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00857714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00857714, "Lapatinib for Treatment of Ductal Carcinoma In Situ (DCIS) of the Breast". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00857714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*